(Q38413575)

2 September 2017

title

Histopathological subclassification of triple negative breast cancer using prognostic scoring system: five variables as candidates (English)

1 reference

2 September 2017

8

Hironobu Sasano

1 reference

2 September 2017

Minoru Miyashita

1

1 reference

2 September 2017

Takanori Ishida

2

1 reference

2 September 2017

Kazuyuki Ishida

3

1 reference

2 September 2017

Kentaro Tamaki

4

1 reference

2 September 2017

Masakazu Amari

5

1 reference

2 September 2017

Mika Watanabe

6

1 reference

2 September 2017

Noriaki Ohuchi

7

1 reference

2 September 2017

publication date

21 November 2010

1 reference

2 September 2017

1 reference

2 September 2017

volume

458

1 reference

2 September 2017

issue

1

1 reference

2 September 2017

page(s)

65-72

1 reference

TIMI Risk Score for ST-Elevation Myocardial Infarction: A Convenient, Bedside, Clinical Score for Risk Assessment at Presentation : An Intravenous nPA for Treatment of Infarcting Myocardium Early II Trial Substudy

2 September 2017

cites work

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS00428-010-1009-2

Vessel density assessed by endoglin expression in breast carcinomas with different expression profiles.

21 January 2018

1 reference

12 December 2020

Gene expression profiling shows medullary breast cancer is a subgroup of basal breast cancers

1 reference

12 December 2020

Triple-negative breast cancer: molecular features, pathogenesis, treatment and current lines of research.

1 reference

12 December 2020

The clinicopathologic characteristics and prognostic significance of triple-negativity in node-negative breast cancer

1 reference

12 December 2020

Significantly higher levels of vascular endothelial growth factor (VEGF) and shorter survival times for patients with primary operable triple-negative breast cancer.

1 reference

12 December 2020

Concentrations of vascular endothelial growth factor in the sera of normal controls and cancer patients

1 reference

12 December 2020

Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

1 reference

12 December 2020

Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma

1 reference

12 December 2020

Molecular portraits of human breast tumours

1 reference

12 December 2020

The triple negative paradox: primary tumor chemosensitivity of breast cancer subtypes

1 reference

12 December 2020

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer

1 reference

12 December 2020

Ki-67 as prognostic marker in early breast cancer: a meta-analysis of published studies involving 12,155 patients

1 reference

12 December 2020

Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis

1 reference

12 December 2020

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

1 reference

12 December 2020

Correlation between MIB-1 and other proliferation markers: clinical implications of the MIB-1 cutoff value

1 reference

12 December 2020

Vascular enumeration as a significant prognosticator for invasive breast carcinoma

1 reference

12 December 2020

Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up

1 reference

12 December 2020

Adjuvant therapy of triple negative breast cancer

1 reference

12 December 2020

Prognostic markers in triple-negative breast cancer

1 reference

12 December 2020

Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.

1 reference

12 December 2020

Basal-like breast cancer: a critical review

1 reference

12 December 2020

Response to neoadjuvant therapy and long-term survival in patients with triple-negative breast cancer

1 reference

12 December 2020

High tumor levels of vascular endothelial growth factor predict poor response to systemic therapy in advanced breast cancer.

1 reference

12 December 2020

Breast cancer subtypes and response to docetaxel in node-positive breast cancer: use of an immunohistochemical definition in the BCIRG 001 trial.

1 reference

12 December 2020

Paclitaxel plus bevacizumab versus paclitaxel alone for metastatic breast cancer

1 reference

12 December 2020

Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications

1 reference

12 December 2020

Triple negative tumours: a critical review

1 reference

12 December 2020

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapy

1 reference

12 December 2020

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma

1 reference

12 December 2020

Current development of clinical inhibitors of poly(ADP-ribose) polymerase in oncology

1 reference

12 December 2020

Response to neoadjuvant therapy and disease free survival in patients with triple-negative breast cancer.

1 reference

12 December 2020

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

1 reference

12 December 2020

The prognostic value of angiogenesis by Chalkley counting in a confirmatory study design on 836 breast cancer patients

1 reference

12 December 2020

Outcome prediction for estrogen receptor-positive breast cancer based on postneoadjuvant endocrine therapy tumor characteristics

1 reference

12 December 2020

Descriptive analysis of estrogen receptor (ER)-negative, progesterone receptor (PR)-negative, and HER2-negative invasive breast cancer, the so-called triple-negative phenotype: a population-based study from the California cancer Registry

1 reference

12 December 2020

Proliferation marker Ki-67 in early breast cancer

1 reference

12 December 2020

Typical medullary breast carcinomas have a basal/myoepithelial phenotype.

1 reference

12 December 2020

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

1 reference

12 December 2020

Tumor angiogenesis and metastasis--correlation in invasive breast carcinoma

1 reference

12 December 2020

Prognostic factors in node-negative breast cancer: a review of studies with sample size more than 200 and follow-up more than 5 years

1 reference

12 December 2020

Basal-like breast cancer defined by five biomarkers has superior prognostic value than triple-negative phenotype

1 reference

12 December 2020

Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

1 reference

12 December 2020

Microvessel density as a prognostic factor in women with breast cancer: a systematic review of the literature and meta-analysis

1 reference

12 December 2020

10.1007/S00428-010-1009-2

Identifiers

DOI

1 reference

2 September 2017

1 reference